ECIA · Encision Inc
Market Cap
$685,314
Shares
16.88M
ECIA metrics
54 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.04
Market cap
$685,314
Price action
19 metricsPrice change (1W)
+0.0%
Price change (30D)
-19.3%
Price change (3M)
+20,200.0%
Price change (6M)
-72.9%
Price change (YTD)
-71.0%
Price change (1Y)
-89.8%
Trailing year
Price change (5Y)
-95.9%
52-week high
$0.39
52-week low
$0.00
Change from 52-week high
-89.6%
Change from 52-week low
+20,200.0%
Annualized volatility
3,871.1%
Beta
—
RSI (14D)
45.7
Price vs SMA 50
-65.9%
Price vs SMA 200
-86.6%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
16.88M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 196.5%
P / book
1.7
reciprocal yield 58.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-11.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 71.3%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 71.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
52.6%
Operating margin
-5.1%
Trailing 12 months
Net margin
-6.0%
Gross profit (TTM)
$3.32M
Operating profit (TTM)
−$319,676
Net income (TTM)
−$380,943
Trailing 12 months
Diluted EPS (TTM)
$-0.03
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-13.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$6.30M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.5%
Year over year · more shares
Revenue CAGR (3Y)
-5.1%
Revenue CAGR (5Y)
-3.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-20.4%
Return on assets
-9.4%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
−$232,238
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
-5.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$71,731
Total assets
$4.06M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$489,796
Capital expenditures (TTM)
—
R&D (TTM)
$665,289
SG&A (TTM)
—
Stock compensation (TTM)
$43,641
R&D / revenue
10.6%
Stock compensation / revenue
0.7%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.1%
Latest settlement · 16.8 days to cover
Days to cover
16.8d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—